Related Experiment Video
Updated: Jun 7, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
Electrical storm in a patient with COVID-19 treated with hydroxychloroquine: A case report
Francesco Vetta1, Leonardo Marinaccio2, Giampaolo Vetta1
1Saint Camillus International University of Health Sciences, Rome, Italy.
Insights
Hydroxychloroquine (HCQ) may increase the risk of dangerous heart arrhythmias, including electrical storms, in COVID-19 patients. Discontinuing HCQ led to stabilization, highlighting the need for cardiac monitoring during treatment.
Area of Science:
- Cardiology
- Infectious Diseases
- Pharmacology
Background:
- Hydroxychloroquine (HCQ) is frequently used for COVID-19 despite controversial efficacy and safety data.
- Cardiac adverse events are known complications of HCQ therapy.
- Electrical storm has not been previously reported in COVID-19 patients or those treated with HCQ.
Observation:
- A 78-year-old male with COVID-19 and an implantable cardiac resynchronization defibrillator (CRT-D) developed an electrical storm.
- The event occurred after several days of home therapy with HCQ.
- The electrical storm correlated with a QTc interval increase.
Findings:
- Discontinuation of HCQ in the intensive care unit resulted in QTc interval reduction.
- Electrical stabilization was observed after HCQ was stopped.
- This case suggests a link between HCQ use and the development of electrical storm.
Implications:
- Highlights a potential risk of HCQ in precipitating serious cardiac arrhythmias.
- Emphasizes the critical need for vigilant electrocardiographic monitoring in patients on HCQ.
- Suggests particular caution in patients with pre-existing cardiac conditions or devices like CRT-D.
Abstract:
Hydroxychloroquine (HCQ) is a widely used drug to treat patients with coronavirus disease 19 (COVID-19). Although evidence of its efficacy and safety remains limited and controversial, both cardiac and non-cardiac adverse events are known to be associated with its use. To our knowledge, electrical storm in patients with COVID-19, or in any case treated with HCQ, has not been reported. We report the case of a 78-year-old male with an implantable cardiac resynchronization defibrillator (CRT-D) and a non-severe form of COVID-19. After a few days of home therapy with HCQ, an electrical storm was revealed that was associated with an increase in QTc. Following admission to the intensive care unit, HCQ was discontinued and progressive reduction of the QTc with electrical stabilization was observed. This clinical case highlights the potential risk of arrythmia associated with the use of HCQ and stresses the need for close electrocardiographic monitoring, especially in patients with established heart disease.
More Related Videos
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
05:03Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function
Published on: December 11, 2019
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Electroconvulsive Therapy